Profil
Doo-Seop Kim worked as a Medicinal Chemist at Merck & Co., Inc. and later as the Head of New Medicine Research Institute at Handok, Inc. He then became the Vice President and Head of Research at Kainos Medicine, Inc. where he worked until 2012.
Dr. Kim holds a doctorate degree from the University of Pittsburgh, a graduate degree from Seoul National University, and an undergraduate degree from Sungkyunkwan University.
Anciens postes connus de Doo-Seop Kim
| Sociétés | Poste | Fin |
|---|---|---|
| HANDOK INC. | Corporate Officer/Principal | 01/01/2015 |
Kainos Medicine, Inc. /old/
 Kainos Medicine, Inc. /old/ BiotechnologyHealth Technology Kainos Medicine, Inc. specializes in the research and development of innovative medicines for brain diseases, cancers, and infectious disease. The company was founded by Ki-Sub Lee and Myung-Cheol Kang on June 15, 2007 and is headquartered in Seongnam-si, South Korea. | Corporate Officer/Principal | 01/11/2012 |
Kainos Medicine, Inc. /old/
Kainos Medicine, Inc. /old/ BiotechnologyHealth Technology Kainos Medicine, Inc. specializes in the research and development of innovative medicines for brain diseases, cancers, and infectious disease. The company was founded by Ki-Sub Lee and Myung-Cheol Kang on June 15, 2007 and is headquartered in Seongnam-si, South Korea. | Directeur Technique/Scientifique/R&D | - |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
Formation de Doo-Seop Kim
| Sungkyunkwan University | Undergraduate Degree |
| Seoul National University | Graduate Degree |
| University of Pittsburgh | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| HANDOK INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Kainos Medicine, Inc. /old/
Kainos Medicine, Inc. /old/ BiotechnologyHealth Technology Kainos Medicine, Inc. specializes in the research and development of innovative medicines for brain diseases, cancers, and infectious disease. The company was founded by Ki-Sub Lee and Myung-Cheol Kang on June 15, 2007 and is headquartered in Seongnam-si, South Korea. | Health Technology |
